Evidence map›Paper›PMID 31401652›Full record

ArticleThe Journal of infectious diseases2019

Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection.

Marc Swidergall, Mina Khalaji, Norma V Solis, David L Moyes, Rebecca A Drummond, Bernhard Hube, Michail S Lionakis, Craig Murdoch, Scott G Filler, Julian R Naglik

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. The pathogenicity and future treatment strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Host targets of candidalysin.PLoS pathogens · 2025
    Review
  17. Article
  18. Microorganisms · 2025
    Review
  19. Review
  20. Advancements in vaginal microbiota,Microbial cell (Graz, Austria) · 2025
    Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 4 countries.

Marc SwidergallDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California.
Mina KhalajiSchool of Clinical Dentistry, Claremont Crescent, University of Sheffield, United Kingdom.
Norma V SolisDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California.
David L MoyesCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, United Kingdom.
Rebecca A DrummondFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Bernhard HubeDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoell Institute), Jena, Germany.
Michail S LionakisFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Craig MurdochSchool of Clinical Dentistry, Claremont Crescent, University of Sheffield, United Kingdom.
Scott G FillerDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California.
Julian R NaglikCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, United Kingdom.
King's College London · GBBaker Heart and Diabetes Institute · AUHarbor–UCLA Medical Center · USLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DENational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USThe Lundquist Institute · USUCLA Medical Center · USUniversity of Sheffield · GB

Funding

Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6M
C. albicans invasion and proliferation during oral infectionR01DE026600 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2017 to 2021
$3.0M
Endothelial invasion by yeast-phase CandidaR01AI124566 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2016 to 2020
$2.7M
Novel Candida albicans host receptors during infection and immune responseK99DE026856 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SWIDERGALL, MARC · 2017 to 2018
$267k
Biotechnology and Biological Sciences Research Council BB/N014677/1Medical Research Council MC_PC_16048Medical Research Council MR/J008303/1NIAID NIH HHS R01 AI124566NIDCR NIH HHS K99 DE026856NIDCR NIH HHS R01 DE026600NIDCR NIH HHS R37 DE022550Wellcome Trust 214229
6 · The paper itself

Abstract

backgroundCandidalysin is a cytolytic peptide toxin secreted by Candida albicans hyphae and has significantly advanced our understanding of fungal pathogenesis. Candidalysin is critical for mucosal C albicans infections and is known to activate epithelial cells to induce downstream innate immune responses that are associated with protection or immunopathology during oral or vaginal infections. Furthermore, candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes. However, the role of candidalysin in driving systemic infections is unknown.

methodsIn this study, using candidalysin-producing and candidalysin-deficient C albicans strains, we show that candidalysin activates mitogen-activated protein kinase (MAPK) signaling and chemokine secretion in endothelial cells in vitro.

resultsCandidalysin induces immune activation and neutrophil recruitment in vivo, and it promotes mortality in zebrafish and murine models of systemic fungal infection.

conclusionsThe data demonstrate a key role for candidalysin in neutrophil recruitment and fungal virulence during disseminated systemic C albicans infections.

Indexed as

Neutrophil InfiltrationAnimalsCandida albicansCandidiasis, InvasiveCytokinesDisease Models, AnimalEndothelial CellsFemaleFungal ProteinsMaleMice, Inbred BALB CSignal TransductionSurvival AnalysisVirulenceVirulence FactorsZebrafishCytokinesECE1 protein, Candida albicansFungal ProteinsVirulence FactorsCandida albicanscandidalysinendothelialfungalsystemic

Identifiers

PMID31401652
PMCPMC6761979
OpenAlexW2966954276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.